Frauenheilkunde up2date, Table of Contents Frauenheilkunde up2date 2014; 8(2): 115-130DOI: 10.1055/s-0033-1357903 Gynäkologische Spezialgebiete und Methoden Georg Thieme Verlag KG Stuttgart · New YorkAnthroposophie und Homöopathie in der Integrativen Medizin Authors Daniela Paepke Evelyn Klein Stefan Paepke Johannes Ettl Marion Kiechle Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Full Text References Literatur 1 Steiner R, Wegmann I. Grundlegendes für eine Erweiterung der Heilkunst. Dornach: Rudolf Steiner Verlag; 1925 2 Bopp A. Die Mistel – Heilpflanze in der Krebstherapie. Zürich: Rüffer und Rub; 2006 3 Wilkens J. Misteltherapie. Differenzierte Anwendung der Mistel nach Wirtsbäumen. Stuttgart: Sonntag Verlag; 2006 4 Kienle GS. Misteltherapie bei Krebs – was ist belegt, was nicht?. Natum Mitteil GynGeburtsh 2009; 11 5 Illert B et al. Supportive care in pancreatic carcinoma UICC stage I–IV patients treated with fermented mistletoe (Viscum album I). Onkologie 2008; 31 (Suppl) Abstr #OP742 6 Friedel E et al. Treatment results with fermented mistletoe (Viscum album I) extract as a part of long-term supportive care in patients with primary non-metastatic colorectal carcinoma. Onkologie 2008; 31 (Suppl. 01) Abstr #OP718 7 Augustin M, Bock P, Hanisch J et al. Sicherheit und Wirksamkeit der komplementären Langzeitbehandlung von primären malignen Melanomen mit mittlerem bis hohem UICC/AJCC-Stadium II und III mittels standardisiertem fermentierten Mistelextrakt (Viscum album L.). Arzneim-Forsch/Drug Res 2005; 55: 38-49 8 Tröger W, Jezdić S, Zdrale Z et al. Quality of life and neutropenia in patiens with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone. Breast Cancer (Auckl) 2009; 3: 35-45 9 Horneber M, Bueschel G, Huber R et al. Mistletoe therapy in oncology. Cochrane Database Syst Rev 2008; (2) CD003297 10 Stumpf C, Rieger S, Fischer IU et al. Retrospektive Untersuchung zur Therapie mit Mistelextrakten bei Patienten mit kolorektalem Karzinom. Dtsch Z Onkol 2007; 39: 12-22 11 Mansky PJ, Wallerstedt DB, Sannes T et al. NCCAM/NCI phase I study of mistletoe extracts and gemcitabine in patients with advanced solid tumors. J Clin Oncol 2010; 28: 15S (Abstr 2559) 12 Burkhart J, Wälchli C, Heusser P et al. In vitro investigation into the potential of mistletoe extract to alleviate adverse effects of cyclophosphamid. Altern Ther Health Med 2010; 16: 40-48 13 Sabová L, Pilátová M, Szilagyi K et al. Cytotoxic effects of mistletoe (Viscum album L.) extract on Jurkat cells and its interaction with doxorubicin. Phytother Res 2010; 24: 365-368 14 Bar-Sela G, Wollner M, Hammer L et al. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomized phase II study. Eur J Cancer 2013; 49: 1058-1064 15 Tröger W, Galun D, Reif M et al. Viscum album (L.) extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival. Eur J Cancer 2013; 49: 3788-3797 16 Weissenstein U, Kunz M, Urech K et al. Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro. BMC Complement Altern Med 2014; 14: 6 17 Stan RL, Hangan AC, Dican L et al. Comparative study concerning mistletoe viscotoxins antitumor activity. Acta Biol Hung 2013; 64: 279-288 18 Tröger W, Zdrale Z, Stancovic N et al. Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone. Breast Cancer (Auckl) 2012; 6: 173-180 19 Ostermann T, Büssing A. Retrolective studies on the survival of cancer patients treated with mistletoe extracts: a meta-analysis. Explore (NY) 2012; 8: 277-281 20 Huber R, Lüdtke H, Wieber J et al. Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters – a placebo controlled clinical trial in healthy subjects. BMC Complement Altern Med 2011; 11: 116 21 Hajto T, Hostanska K, Frei K et al. Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990; 50: 3322-3326 22 Kienle G. Misteltherapie bei Krebs – was ist belegt, was nicht?. Natum Mitteilung Gynäkologie und Geburtshilfe 2009; 11: 52-53 23 Steiner R. Geisteswissenschaftliche Grundlagen zum Gedeihen der Landwirtschaft. GA 327. Dornach: Rudolf Steiner Verlag; 1924 24 Köhler G. Lehrbuch der Homöopathie. 1. Grundlagen und Anwendung. 9.. Aufl. Stuttgart: Hippokrates; 2008 25 Gawlik W. Arzneimittelbild und Persönlichkeitsportrait: Konstitutionsmittel in der Homöopathie. 5.. Aufl. Stuttgart: Hippokrates; 2008 26 Engelsing AM. Homöopathie ganz weiblich, Die sanfte Methode für umfassendes Wohlbefinden. Stuttgart: Trias; 2008 27 Shang A, Huwiler-Müntener K, Nartey L et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366: 726-732 28 Frenkel M, Mishra BM, Sen S et al. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 2010; 36: 395-403 29 Kassab S, Cummings M, Berkovitz S et al. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2009; (2) CD0004845
